Correlation Between Forte Biosciences and Cynata Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Forte Biosciences and Cynata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Forte Biosciences and Cynata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Forte Biosciences and Cynata Therapeutics Limited, you can compare the effects of market volatilities on Forte Biosciences and Cynata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Forte Biosciences with a short position of Cynata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Forte Biosciences and Cynata Therapeutics.

Diversification Opportunities for Forte Biosciences and Cynata Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Forte and Cynata is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Forte Biosciences and Cynata Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cynata Therapeutics and Forte Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Forte Biosciences are associated (or correlated) with Cynata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cynata Therapeutics has no effect on the direction of Forte Biosciences i.e., Forte Biosciences and Cynata Therapeutics go up and down completely randomly.

Pair Corralation between Forte Biosciences and Cynata Therapeutics

If you would invest  568.00  in Forte Biosciences on September 13, 2024 and sell it today you would earn a total of  1,800  from holding Forte Biosciences or generate 316.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Forte Biosciences  vs.  Cynata Therapeutics Limited

 Performance 
       Timeline  
Forte Biosciences 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Forte Biosciences are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Forte Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.
Cynata Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cynata Therapeutics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Cynata Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Forte Biosciences and Cynata Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Forte Biosciences and Cynata Therapeutics

The main advantage of trading using opposite Forte Biosciences and Cynata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Forte Biosciences position performs unexpectedly, Cynata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cynata Therapeutics will offset losses from the drop in Cynata Therapeutics' long position.
The idea behind Forte Biosciences and Cynata Therapeutics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account